MAQUET GmbH made an offer to acquire PULSION Medical Systems SE (XTRA:PUS) for approximately €140 million in cash on December 4, 2013. Getinge has made an offer of €16.9 per share in cash. The transaction will be financed through a new credit facility. The offer will be subject to the terms and conditions to be set forth in the offer document. The completion of the transaction will be conditional on a certain percentage of Pulsion's shareholders tendering their shares and approval from the competition authorities. The transaction is expected to be completed in the first quarter of 2014. As of December 5, 2013, the offer was approved by shareholders representing 70% of outstanding shares in PULSION. As of January 14, 2014, as part of the acquisition process, the publication of the offer document waxs approved by the German Federal Financial Supervisory Authority. The acceptance period is from January 14, 2014 to February 12, 2014. Getinge has already secured the acquisition of 74.6% of the shares in Pulsion. As of February 7, 2014, the transaction was approved by German Federal Cartel Office. Getinge has secured 76.88% of the outstanding shares and voting rights in Pulsion, which corresponds to 6.34 million shares in Pulsion. The board of Pulsion has recommended the Pulsion shareholders to accept the public tender offer.

Zoran Stambolovski and Rickard Carrick of Mannheimer Swartling Advokatbyrå AB acted as legal advisors to Getinge. Albert Schröder, Barbara Mayer, Hendrik Thies, Gerhard Manz, Stefan Daub, Norbert Hebeis, Morton Douglas, Hans-Georg Riegger, Frank Jungfleisch, Tobias Lenz, Tobias Lenz, Friederike Schäffler, Gundo Haacke, Jan Henning Martens, Oliver Wasmeier, Eva Kessler, Anne Bongers-Gehlert, Sebastian Hoegl, Stephanie Krüger, Lisa Kanstinger, Sven Ufe Tjarks and Mike Weitzel of Friedrich Graf von Westphalen & Partner acted as legal advisors for MAQUET. MLawGroup acted as legal advisor and Ferghana Partners Group acted as financial advisor for PULSION Medical Systems.